Evaluation of the Tolerability of Cagrilintide in Participants Not Tolerating GLP-1-RA Therapies Due to Gastrointestinal Adverse Events
Public ClinicalTrials.gov record NCT07607587. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Tolerability of Cagrilintide in People With Obesity That Discontinued GLP-1-RA Therapies Due to Gastrointestinal Adverse Events: a Double-blinded Randomised Feasibility Study
Study identification
- NCT ID
- NCT07607587
- Recruitment status
- Recruiting
- Study type
- Interventional
- Phase
- Phase 1
- Lead sponsor
- Novo Nordisk A/S
- Industry
- Enrollment
- 114 participants
Conditions and interventions
Conditions
Interventions
- Cagrilintide Drug
- Placebo (matched to Cagrilintide) Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- May 28, 2026
- Primary completion
- Nov 18, 2027
- Completion
- Nov 18, 2027
- Last update posted
- Jun 24, 2026
2026 – 2027
United States locations
- U.S. sites
- 11
- U.S. states
- 6
- U.S. cities
- 11
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Diablo Clinical Research, Inc. | Walnut Creek | California | 94598 | Recruiting |
| Northeast Research Institute | Fleming Island | Florida | 32003 | Recruiting |
| Jacksonville Ctr For Clin Res | Jacksonville | Florida | 32216 | Recruiting |
| Center for Diab,Obes & Metab | Pembroke Pines | Florida | 33024 | Recruiting |
| Encore Medical Research of Weston | Weston | Florida | 33331 | Recruiting |
| Monroe Biomedical Research, LLC | Monroe | North Carolina | 28112 | Recruiting |
| Accellacare | Wilmington | North Carolina | 28401 | Recruiting |
| Coastal Carolina Research Ctr | North Charleston | South Carolina | 29405 | Not yet recruiting |
| Holston Medical Group_Bristol | Bristol | Tennessee | 37620 | Recruiting |
| Amarillo Medical Specialists | Amarillo | Texas | 79124 | Recruiting |
| Elligo Clin Res Centre | Austin | Texas | 78704 | Recruiting |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT07607587, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jun 24, 2026 · Synced Jul 24, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT07607587 live on ClinicalTrials.gov.